Leo Pharma Eyes $800 Million Deal Push as IPO Plans Advance
Leo Pharma is actively seeking more acquisition targets, with as much as 5 billion kroner ($800 million) to spend on dealmaking as it positions itself for an initial public offering, according to its top management.
ORIGINAL SOURCE →via Bloomberg Markets
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] Orta Doğu gerilimi küresel piyasaları sarstı: Petrol, altın, borsa ve Fed beklentilerinde son durum
- [FINANCE] First Abu Dhabi Bank to expand Islamic digital banking offerings with Temenos
- [FINANCE] DeFi Technologies Inc. (NASDAQ:DEFT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
- [FINANCE] Earnings call transcript: Fagerhult’s Q1 2026 results disappoint, stock down 6%
- [FINANCE] Piper Sandler cuts Tractor Supply stock rating on pet trends
- [FINANCE] Indonesia stocks higher at close of trade; IDX Composite Index up 0.91%